hers wegovy - Search News

News

Hims & Hers stock plummets

MarketWatch on MSN · 4d

Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.

Hims & Hers Health’s stock booked record losses Monday after Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth company less than two months after it started.

Fast Company on MSN · 4d

Hims & Hers stock plummets after Novo Nordisk ends partnership over ‘knockoff’ Wegovy

This morning, the Danish pharmaceutical giant Novo Nordisk announced the abrupt end of its brief partnership with telehealth company Hims & Hers Health (NYSE: HIMS), citing concerns over Hims & Hers’ “knockoff” weight-loss drugs. Now, Hims & Hers’ shares are plummeting as investors react to the news.

The Motley Fool on MSN · 19h

Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?

The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's largest pharmaceutical companies.

4don MSN

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

5h

Without GLP-1 Hims & Hers Is A $20s Per Share Stock -- Sell Call

Novo Nordisk ends partnership with Hims & Hers, causing a 35% plunge. With no near-term catalysts, learn why investors must ...

3d

Novo Nordisk ends collaboration with Hims & Hers for discounted weight loss meds

Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for ...

1d

Hims & Hers Sued Over Wegovy Maker’s Exit, Record Stock Selloff

Hims & Hers Health Inc. investors have sued the telehealth provider days after Novo Nordisk A/S announced it was ending the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results